Alexander's (ALX) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is ALX's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

Expect to report safety and early efficacy data from the Phase 1 dose-escalation study of ALX2004 in EGFR-expressing solid tumors and plan to host a KOL webinar to review the results in December 2026 Topline data from 12…

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat c…

Alexander's, Inc. (ALX) Q3 2026 Earnings Call Transcript…

Vornado Realty Trust reported higher third-quarter comparable funds from operations and continued leasing momentum across its New York office portfolio, as management pointed to rising rents, tightening availability of h…

Alexander's (ALX) came out with quarterly funds from operations (FFO) of $7.07 per share, missing the Zacks Consensus Estimate of $8.2 per share. This compares to FFO of $2.91 per share a year ago.…

PARAMUS, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- ALEXANDER'S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2026 today and reported:…

Alexander's, Inc. (NYSE: ALX - Get Free Report)'s share price crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $251.59 and traded as high as $254.50. Alexander'…

PARAMUS, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable on November 20, 2026 to stoc…

PARAMUS, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended September 30, 2026 with the U.S. Securities and Exc…

High-yield 'mousetrap' REITs consistently underperform, with average returns lagging the VNQ by 1090–1380 bps due to dividend cuts and price declines. Dividend Safety grades of F indicate a roughly 40% chance of a cut wi…

Alexander's (NYSE: ALX - Get Free Report) and Essential Properties Realty Trust (NYSE: EPRT - Get Free Report) are both real estate companies, but which is the better investment? We will compare the two companies based o…

Alexander's, Inc. (NYSE: ALX - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $256.52 and traded as low as $247.02. Alexander's…

Achieved 40.3% ORR with evorpacept plus trastuzumab, ramucirumab and paclitaxel versus 26.6% for control, with response rates increasing to 63.6% versus 23.1% among patients with high CD47 expression and retained HER2-po…

Alexander's (NYSE: ALX - Get Free Report) and Tritax Big Box REIT (OTCMKTS:TTBXF - Get Free Report) are both real estate companies, but which is the better business? We will contrast the two companies based on the streng…

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat …

Here is how Alexander's (ALX) and Healthpeak (DOC) have performed compared to their sector so far this year.…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 12. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

